FNBP1 activators represent a class of chemical compounds that target and modulate the activity of the Formin-binding protein 1 (FNBP1). As a crucial component involved in the regulation of the actin cytoskeleton, FNBP1 plays an important role in various cellular functions, including cell shape, motility, and adhesion. The protein achieves its role by interacting with formin proteins, which are potent actin nucleators and polymerization factors. FNBP1 activators are designed to enhance the activity of FNBP1, potentially influencing its interactions with formin proteins and, consequently, modulating actin dynamics. The mechanism of activation often involves the stabilization of FNBP1 in a conformation that promotes its activity or enhances its interaction with binding partners. To achieve such specificity, FNBP1 activators are typically designed to interact with precise domains within the protein, such as the proline-rich regions or the SH3 domain, which are known to be critical for its function.
Chemically, FNBP1 activators are diverse, mirroring the complexity of the protein's structure and the sophisticated nature of the protein-protein interactions it mediates. These activators may include small molecules that mimic natural ligands or peptides, or they may be novel synthetic compounds identified through various biophysical and biochemical screening approaches. The development of these activators often relies on detailed knowledge of FNBP1's structure, gleaned from techniques such as X-ray crystallography and NMR spectroscopy. This structural insight informs the design of molecules that can precisely fit into or alter the protein's active or binding sites. In designing FNBP1 activators, researchers aim to optimize the compounds for high specificity and a strong affinity for FNBP1, while also ensuring that the molecules possess suitable chemical properties for stability and cell permeability.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine can potentially stimulate the production of FNBP1 by activating signaling cascades that specifically upregulate FNBP1 gene transcription. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone might bind to the glucocorticoid receptor, which could then bind to the promoter of the FNBP1 gene and amplify its transcription, leading to an increase in FNBP1 protein levels. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid may bind to and activate retinoic acid receptors, which could then initiate the transcription of FNBP1, leading to an increase in FNBP1 protein synthesis. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol might bind to estrogen receptors, which could then bind to the promoter of the FNBP1 gene and stimulate its transcription, potentially increasing FNBP1 protein production. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride, by inhibiting GSK-3β, could potentially increase the transcription of genes like FNBP1 that might be suppressed by GSK-3β activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, by increasing cellular levels of cAMP, could potentially initiate signaling cascades that lead to the transcriptional upregulation of FNBP1. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, by inhibiting tyrosine kinases, could potentially stimulate transcriptional machinery to increase FNBP1 transcription and subsequent protein synthesis. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, by inhibiting histone deacetylases, could potentially increase acetylation at the FNBP1 gene, enhancing its transcription and thus promoting FNBP1 protein production. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, by inhibiting DNA methylation at the FNBP1 gene, could potentially increase its transcription, leading to an upregulation of FNBP1 protein synthesis. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate, by inhibiting histone deacetylases, could potentially increase acetylation at the FNBP1 gene, thus amplifying its transcription and stimulating FNBP1 protein production. | ||||||